Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $30.6800 (2.33%) ($30.6800 - $30.7400) on Thu. Sep. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.55% (three month average) | RSI | 77 | Latest Price | $30.6800(2.33%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX advances 4.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(69%) ARKG(65%) ARKK(60%) IBB(60%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -2.275% in a week (0% probabilities). VIXM(-46%) VXX(-39%) UUP(-19%) IGOV(-8%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.275% (StdDev 4.55%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $30.1(1.93%) | 10 Day Moving Average | $30.13(1.83%) | 20 Day Moving Average | $28.16(8.95%) | To recent high | -24.2% | To recent low | 41.5% | Market Cap | $3.886b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |